Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue?
OBJECTIVES: Transurethral microwave thermotherapy is useful for the treatment of benign prostatic hyperplasia, but its effect on cancer is not documented. We analyzed the pathologic changes occurring after microwave thermotherapy in whole mount radical prostatectomy specimens from patients with cancer. METHODS: Nine patients scheduled for radical prostatectomy for clinically localized prostate cancer were treated with transurethral microwave thermotherapy (Urologix Targis System). Patients ranged in age from 64 to 72 years (mean 68). Seven patients underwent prostatectomy 4 to 90 hours after thermotherapy, and 2 other patients underwent prostatectomy 12 months after thermotherapy. Whole mount totally embedded prostates were mapped for necrosis and cancer, and the volume of each was measured by the grid method. RESULTS: Pathologic stages were T2a (n = 4), T2b (n = 4), and T3b (n = 1). The prostates from patients who underwent radical prostatectomy within 4 to 90 hours of thermotherapy h
Related Questions
- Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue?
- Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate?
- Are clinical characteristics of familial benign prostatic hyperplasia different than in sporadic cases?
